UrologySchool.com

OTHER GU ONCOLOGY: PENILE TUMOURS

Benign Tumours

 

Pearly penile papules

Source: Wikipedia

 

Premalignant cutaneous lesions

 

Penile verrucous carcinoma

Verrucous Carcinoma of the Penis

Source: Wikipedia

 

Squamous Cell Carcinoma of the Penis

 

 

 

Lymph node status

Management

No palpable inguinal nodes (cN0)

Tis, Ta G1, T1G1: surveillance.

> T1G2 [2019 NCCN guidelines: T1b or ≥T2]: invasive lymph node staging by either bilateral modified inguinal lymphadenectomy (the medial superficial inguinal lymph nodes and those from the central zone are removed bilaterally, leaving the greater saphenous vein untouched) or dynamic sentinel node biopsy

Palpable inguinal nodes (cN1/cN2)

Palpably enlarged groin lymph nodes should be surgically removed, pathologically assessed (by frozen section) and, if positive, a radical [bilateral?] inguinal lymphadenectomy should be performed

Fixed inguinal lymph nodes (cN3)

Neoadjuvant chemotherapy followed by radical inguinal lymphadenectomy in responders

Pelvic lymph nodes

Ipsilateral pelvic lymphadenectomy if ≥2 inguinal nodes are involved on one side or if extracapsular nodal metastasis (pN3) reported.

Adjuvant chemotherapy

In pN2/pN3 patients after radical lymphadenectomy

Radiotherapy

Not recommended for nodal disease except as a palliative option

Non-squamous penile malignant neoplasms
Questions
  1. List the premalignant lesions of the penis.
  2. What is the risk of progression of Bowenoid papulosis? Verrucous carcinoma? Erythroplaysia of Querat? Bowen disease?
  3. List risk factors for penile cancer
  4. Describe the lymphatic drainage of the penis
  5. What is the work-up of a patient with suspected penile cancer?
  6. What form of imaging of the primary tumour is preferred?
  7. Which patients should undergo imaging to evaluate lymph node metastases?
  8. What is the name of the classification system used in grading penile cancer?
  9. What are the risk factors for nodal mestastasis?
  10. Describe the pTNM staging of penile cancer
  11. Describe the management options of the primary lesion in penile cancer
  12. What is the recommended margin on circumcision for CIS?
  13. What are the indications for partial or total penectomy
  14. What is the most important prognostic factor for survival?
  15. What are the prognostic factors following inguinal lymph node dissection for penile cancer?
  16. Which patients may be treated with primary radiotherapy for invasive penile carcinoma?
  17. What is the recommended margin in extra-mammary Paget’s disease?
  18. What is the most presentation of metastasis to the penis?
Answers
  1. List the premalignant lesions of the penis.
    • HPV-related (4): Bowenoid papulosis, verrucous carcinoma, Erythroplasia of Querat, Bowen disease
    • Non-HPV related (5): Kaposi sarcoma, cutaneous horn, leukoplakia, lichen schlerosis, pseudoepitheliomatous micaceous and keratotic balanitis
  2. What is the risk of progression of Bowenoid papulosis? Verrucous carcinoma? Erythroplaysia of Querat? Bowen disease?
    • 1%, 30%, 30%, 5%
  3. List risk factors for penile cancer
    1. Lack of circumcision
    2. Phimosis
    3. Lichen sclerosus, chronic penile inflammation
    4. HPV (subtype 16 most frequently)
    5. Tobacco exposure (smoking, chewing tobacco)
    6. Poor hygiene, rural areas, low socioeconomic status, unmarried
    7. Number of sexual partners, early age of sexual intercourse
    8. Penile trauma
    9. Sporalene and ultraviolet A phototherapy (PUVA)
  4. Describe the lymphatic drainage of the penis
    • Foreskin and skin of the penile shaft drain into the right and left superficial inguinal nodes
    • Glans drains into the superficial inguinal nodes and the deep inguinal nodes
    • Penile cancer can metastasize to contralateral inguinal nodes because of crossover in the symphyseal region
    • Drainage subsequently proceeds from the inguinal nodes to the ipsilateral pelvic lymph nodes (external iliac, internal iliac, and obturator)
  5. What is the work-up of a patient with suspected penile cancer?
    • History and physical exam (including exam of nodes), serum calcium, penile doppler US for larger/invasive lesions, metastatic imaging (if indicated)
  6. What form of imaging of the primary tumour is preferred?
    • Penile doppler US
  7. Which patients should undergo imaging to evaluate lymph node metastases?
    • Patients in whom physical exam unreliable (obesity, previous surgery in inguinal area)
  8. What is the name of the classification system used in grading penile cancer?
    • Broder
  9. What are the risk factors for nodal mestastasis?
    1. Stage (depth of invasion)
    2. Grade
    3. Lymphovascular invasion
    4. Perineural invasion
  10. Describe the pTNM staging of penile cancer
    • Primary tumour (T)
      • TX: Primary tumour cannot be assessed
      • T0: No evidence of primary tumour
      • Tis: Carcinoma in situ
      • Ta: non-invasive squamous cell carcinoma types including basaloid, warty, verrucous, papillary, and mixed types
      • T1
        • T1a: Tumour invades subepithelial connective tissue without lymphovascular invasion, perineural invasion, and is not high grade (i.e. grade 3-4 or sarcomatoid)
        • T1b: Tumour invades subepithelial connective tissue WITH lymphovascular invasion, perineural invasion, or high grade (i.e. grade 3-4 or sarcomatoid)
      • T2: Tumour invades corpora spongiosum
      • T3: Tumour invades corpus cavernosum
      • T4: Tumour invades other adjacent structures
    • Lymph nodes (N)
      • Clinical
        • cNX: Regional nodes cannot be assessed
        • cN0: No palpable or visibly enlarged inguinal lymph nodes
        • cN1: unilateral, mobile inguinal lymph nodes
        • cN2: ≥2 unilateral, mobile inguinal lymph nodes or bilateral inguinal lymph nodes
        • cN3: palpable, fixed nodal mass, regardless of the size or unilateral/bilateral involvement
      • Pathological
        • pNX: Regional nodes cannot be assessed
        • pN0: No regional lymph node metastasis
        • pN1: up to 2 unilateral positive inguinal lymph nodes
        • pN2: ≥3 unilateral lymph nodes or bilateral inguinal lymph nodes
        • pN3: Extra-nodal extension or pelvic lymph node(s)
    • Distant metastasis (M)
      • M0: No distant metastasis (no pathologic M0; use clinical M to complete staging group)
      • M1: Distant metastasis
        • Lymph node metastasis outside the true pelvis, or to visceral or bone sites
  11. Describe the management options of the primary lesion in penile cancer
    • CIS
      • Non-surgical
        • Topical: 5-FU, imiquimod
        • Laser ablation
      • Surgical: limited excision/circumcision
      • Radiation
      • Mohs surgery
    • Favourable histologic features (stage Ta, T1; grade 1 and 2)
      • Organ-sparing or glans-sparing surgical procedures: Mohs surgery, laser ablation, radiation therapy, limited excision strategies, and glansectomy
  12. What is the recommended margin on circumcision for CIS?
    • 5mm
  13. What are the indications for partial or total penectomy
    1. High grade (grade ≥ 3) lesions
    2. [stage ≥ T2]; deep invasion into the glans urethra or corpora cavernosa
    3. Tumours >4cm
  14. What is the most important prognostic factor for survival?
    • Lymph node metastasis
  15. What are the prognostic factors following inguinal lymph node dissection for penile cancer?
    1. Unilateral involvement
    2. Minimal nodal disease (up to 2 involved nodes in most series)
    3. No evidence of extra nodal extension of cancer
    4. Absence of pelvic nodal metastases
  16. Which patients may be treated with primary radiotherapy for invasive penile carcinoma?
    • T1-2 tumours and <4cm; circumcision is necessary before
  17. What is the recommended margin in extra-mammary Paget’s disease?
    • 3cm
  18. What is the most presentation of metastasis to the penis?
    • Priapism
References